Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

647 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of fluvastatin on long-term outcome after coronary revascularization with stent implantation.
Saia F, de Feyter P, Serruys PW, Lemos PA, Arampatzis CA, Hendrickx GR, Delarche N, Goedhart D, Lesaffre E, Branzi A; Lescol Intervention Prevention Study (LIPS) Investigators. Saia F, et al. Among authors: de feyter p. Am J Cardiol. 2004 Jan 1;93(1):92-5. doi: 10.1016/j.amjcard.2003.08.076. Am J Cardiol. 2004. PMID: 14697476 Free article. Clinical Trial.
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy).
Lemos PA, Serruys PW, de Feyter P, Mercado NF, Goedhart D, Saia F, Arampatzis CA, Soares PR, Ciccone M, Arquati M, Cortellaro M, Rutsch W, Legrand V. Lemos PA, et al. Among authors: de feyter p. Am J Cardiol. 2005 Feb 15;95(4):445-51. doi: 10.1016/j.amjcard.2004.10.008. Am J Cardiol. 2005. PMID: 15695126 Free article. Clinical Trial.
Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance.
Agostoni P, Valgimigli M, Van Mieghem CA, Rodriguez-Granillo GA, Aoki J, Ong AT, Tsuchida K, McFadden EP, Ligthart JM, Smits PC, de Jaegere P, Sianos G, Van der Giessen WJ, De Feyter P, Serruys PW. Agostoni P, et al. Among authors: de feyter p, de jaegere p. Am J Cardiol. 2005 Mar 1;95(5):644-7. doi: 10.1016/j.amjcard.2004.10.042. Am J Cardiol. 2005. PMID: 15721110
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.
Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, de Jaegere PP, de Feyter P, van Domburg RT, Serruys PW. Ong AT, et al. Among authors: de feyter p, de jaegere pp. J Am Coll Cardiol. 2005 Mar 15;45(6):947-53. doi: 10.1016/j.jacc.2004.09.079. J Am Coll Cardiol. 2005. PMID: 15766834 Free article. Clinical Trial.
One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries.
Rodriguez-Granillo GA, Valgimigli M, Garcia-Garcia HM, Ong AT, Aoki J, van Mieghem CA, Tsuchida K, Sianos G, McFadden E, van der Giessen WJ, van Domburg R, de Feyter P, Serruys PW. Rodriguez-Granillo GA, et al. Among authors: de feyter p. J Invasive Cardiol. 2005 Aug;17(8):409-12. J Invasive Cardiol. 2005. PMID: 16079445
647 results